Dados B3 › ALOS3 × RADL3
ALOS3 × RADL3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | ALOS3 | RADL3 | year |
|---|---|---|---|
| ROE | 6.3% | 18.9% | 2025 |
| ROIC | 12.9% | 24.8% | 2025 |
| ROA | 3.5% | 5.5% | 2025 |
| Gross margin | 73.9% | 29.3% | 2025 |
| EBIT margin | 53.8% | 6.2% | 2025 |
| Net margin | 33.1% | 2.9% | 2025 |
| Net debt/EBITDA | -1.12x | 0.69x | 2025 |
| Current ratio | 2.58x | 1.46x | 2025 |
| Revenue growth (1y) | 4.4% | 13.8% | 2025 |
| Revenue growth (5y CAGR) | 29.1% | 17.1% | 2025 |
| Piotroski F-Score | 8/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | ALOS3 | RADL3 | year |
|---|---|---|---|
| P/E | 18.49x | 32.24x | 2025 |
| P/B | 1.17x | 5.71x | 2025 |
| EV/EBITDA | 5.97x | 9.37x | 2025 |
| FCF yield | 10.4% | 2.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:39 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:39 UTC. If this does not match /saude, you are reading a cached copy.